{"id":"ophthalmic-saline-eye-drops","safety":{"commonSideEffects":[{"rate":"null","effect":"Eye irritation"}]},"_chembl":{"chemblId":"CHEMBL2108783","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They do not have a specific pharmacological mechanism of action, but rather serve as a vehicle for delivering other treatments or providing a protective barrier for the eye. The isotonic solution helps to maintain the natural balance of fluids in the eye.","oneSentence":"Ophthalmic saline eye drops work by providing a sterile, isotonic solution to flush out debris and maintain eye health.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:24:27.582Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome"},{"name":"Conjunctivitis"},{"name":"Iritis"}]},"trialDetails":[{"nctId":"NCT07151612","phase":"PHASE4","title":"The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia","status":"COMPLETED","sponsor":"Shanxi Eye Hospital","startDate":"2025-09-04","conditions":"Presbyopia","enrollment":62},{"nctId":"NCT07449000","phase":"NA","title":"Losartan for Corneal Fibrosis","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2026-02-12","conditions":"Corneal Scarring Fibrosis","enrollment":46},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT04838223","phase":"","title":"Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)","status":"SUSPENDED","sponsor":"Tufts Medical Center","startDate":"2021-07-02","conditions":"Dry Eye, Neuropathic Pain","enrollment":1000},{"nctId":"NCT06271772","phase":"PHASE3","title":"Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Bacterial Keratitis","enrollment":60},{"nctId":"NCT04007276","phase":"PHASE4","title":"The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Tulane University","startDate":"2026-11-10","conditions":"Glaucoma, Glaucoma, Open-Angle, Glaucoma; Drugs","enrollment":60},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT07154147","phase":"PHASE4","title":"Oral vs IV Sedation for Cataract Surgery in Older Adults","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-08-12","conditions":"Cataract Surgery, Sedation, Cognition Function","enrollment":20},{"nctId":"NCT06329661","phase":"PHASE4","title":"A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine","status":"COMPLETED","sponsor":"Novaliq GmbH","startDate":"2024-04-22","conditions":"Dry Eye Disease","enrollment":204},{"nctId":"NCT07124143","phase":"NA","title":"The Effect of Platelet-Rich Plasma on Wound Healing After Gingivectomy","status":"COMPLETED","sponsor":"Duygu Kilic","startDate":"2021-06-02","conditions":"Gingival Overgrowth","enrollment":38},{"nctId":"NCT06352541","phase":"PHASE1","title":"Study Evaluating PRO-232 an Ophthalmic Solution Compared to Placebo.","status":"NOT_YET_RECRUITING","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2025-09-30","conditions":"Healthy","enrollment":28},{"nctId":"NCT07050446","phase":"PHASE3","title":"Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye","status":"COMPLETED","sponsor":"Jadran Galenski laboratorij d.d.","startDate":"2024-03-20","conditions":"Dry Eye Disease (DED)","enrollment":86},{"nctId":"NCT03911271","phase":"PHASE2","title":"Low-dose Atropine for the Prevention of Myopia Progression in Danish Children","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2019-05-30","conditions":"Myopia","enrollment":97},{"nctId":"NCT06655441","phase":"PHASE4","title":"The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function","status":"NOT_YET_RECRUITING","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2025-09-01","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT07000565","phase":"NA","title":"The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-11-01","conditions":"Ocular Surface Disease","enrollment":42},{"nctId":"NCT06242379","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2024-05-23","conditions":"Retinitis Pigmentosa","enrollment":15},{"nctId":"NCT03733899","phase":"NA","title":"An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens Discomfort","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2018-11-07","conditions":"Visual Acuity","enrollment":22},{"nctId":"NCT03298815","phase":"PHASE1, PHASE2","title":"Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)","status":"COMPLETED","sponsor":"University of Utah","startDate":"2019-12-20","conditions":"Ocular Graft Versus Host Disease","enrollment":15},{"nctId":"NCT03865160","phase":"PHASE2, PHASE3","title":"Low-dose Atropine for Myopia Control in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Eye Hospital, Freiburg","startDate":"2021-10-19","conditions":"Myopia, Progressive","enrollment":302},{"nctId":"NCT06851364","phase":"PHASE2","title":"Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants","status":"COMPLETED","sponsor":"International Islamic University Malaysia","startDate":"2022-10-30","conditions":"Dry Eye","enrollment":45},{"nctId":"NCT02510235","phase":"NA","title":"Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2015-03-09","conditions":"Dry Eye Syndrome, Tear Film Insufficiency","enrollment":56},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT02707120","phase":"PHASE4","title":"Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis","status":"WITHDRAWN","sponsor":"Biotechnology Institute IMASD","startDate":"2018-01-04","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT05666362","phase":"PHASE4","title":"Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-20","conditions":"Preterm","enrollment":68},{"nctId":"NCT06048380","phase":"PHASE3","title":"The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery","status":"RECRUITING","sponsor":"Singapore Eye Research Institute","startDate":"2025-03-01","conditions":"Fuchs' Endothelial Dystrophy, Cataract","enrollment":120},{"nctId":"NCT06565650","phase":"PHASE4","title":"A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bausch & Lomb Incorporated","startDate":"2024-07-31","conditions":"Dry Eye","enrollment":216},{"nctId":"NCT06673784","phase":"","title":"Evaluation and Risk Factors of Post-traumatic Endophthalmitis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-11-10","conditions":"Endophthalmitis","enrollment":41},{"nctId":"NCT02507934","phase":"NA","title":"Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2015-06-26","conditions":"Dry Eye Syndrome","enrollment":40},{"nctId":"NCT06533995","phase":"NA","title":"The Usefulness of Visuprime in Cataract Surgery","status":"COMPLETED","sponsor":"VISUfarma SpA","startDate":"2021-10-25","conditions":"Cataract","enrollment":75},{"nctId":"NCT04192994","phase":"NA","title":"Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2019-01-01","conditions":"Endophthalmitis","enrollment":25},{"nctId":"NCT04281004","phase":"PHASE1, PHASE2","title":"Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-07-10","conditions":"Photorefractive Keratectomy","enrollment":61},{"nctId":"NCT06365762","phase":"PHASE1, PHASE2","title":"The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract","status":"COMPLETED","sponsor":"Livionex Inc.","startDate":"2006-01-01","conditions":"Age Related Cataracts","enrollment":111},{"nctId":"NCT06323395","phase":"PHASE3","title":"Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry Eye","status":"COMPLETED","sponsor":"Jadran Galenski laboratorij d.d.","startDate":"2022-06-01","conditions":"Dry Eye Disease","enrollment":64},{"nctId":"NCT06317922","phase":"NA","title":"Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF Injections","status":"RECRUITING","sponsor":"Francesco Bandello","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":60},{"nctId":"NCT05390840","phase":"PHASE2","title":"A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD)","status":"UNKNOWN","sponsor":"Theratocular Biotek Co.","startDate":"2022-08-09","conditions":"Age-Related Macular Degeneration","enrollment":36},{"nctId":"NCT06294015","phase":"PHASE4","title":"Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.","status":"NOT_YET_RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2024-03","conditions":"Corneal Epitheliopathy, Glaucoma, Corneal Disease","enrollment":25},{"nctId":"NCT05321251","phase":"PHASE2, PHASE3","title":"Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2022-06-01","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT06034366","phase":"NA","title":"the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-10-01","conditions":"Myopia","enrollment":150},{"nctId":"NCT01685398","phase":"PHASE3","title":"Topical Timolol for Superficial Infantile Hemangioma","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2012-09","conditions":"Hemangioma","enrollment":48},{"nctId":"NCT00816413","phase":"PHASE1, PHASE2","title":"Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2008-09","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":""},{"nctId":"NCT05713981","phase":"NA","title":"The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression","status":"COMPLETED","sponsor":"University of the Incarnate Word","startDate":"2023-03-01","conditions":"Meibomian Gland Dysfunction","enrollment":40},{"nctId":"NCT04290039","phase":"PHASE1","title":"Sublingual vs IV Atropine Bioavailability Study","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2020-01-04","conditions":"Toxic Effect of Organophosphate and Carbamate Insecticides","enrollment":15},{"nctId":"NCT04510428","phase":"PHASE2","title":"OSIG-eye Drops Treatment for Dry Eye Disease","status":"WITHDRAWN","sponsor":"University of Illinois at Chicago","startDate":"2023-05-15","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT05855486","phase":"NA","title":"PMCF Study to Evaluate Performance and Safety of \"LUXIDROPIN BABY & JUNIOR\"","status":"COMPLETED","sponsor":"C.O.C. Farmaceutici S.r.l.","startDate":"2022-10-12","conditions":"Ocular Discharge","enrollment":32},{"nctId":"NCT05165082","phase":"NA","title":"The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study","status":"COMPLETED","sponsor":"Taipei Medical University WanFang Hospital","startDate":"2021-12-21","conditions":"Paronychia, Epidermal Growth Factor Receptor Inhibitor","enrollment":8},{"nctId":"NCT04831047","phase":"PHASE4","title":"The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance","status":"COMPLETED","sponsor":"University of Miami","startDate":"2021-06-08","conditions":"Ptosis, Eyelid, Conjunctiva Inflamed, Eye Manifestations","enrollment":114},{"nctId":"NCT02978183","phase":"PHASE2","title":"Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Noveome Biotherapeutics, formerly Stemnion","startDate":"2016-12","conditions":"Allergic Conjunctivitis","enrollment":70},{"nctId":"NCT04938908","phase":"PHASE2","title":"Probiotic in Dry Eye Syndromes","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2021-07-01","conditions":"Dry Eye Syndrome","enrollment":40},{"nctId":"NCT05784519","phase":"EARLY_PHASE1","title":"Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2023-06-01","conditions":"Mesenchymal Stem Cell, Dry Eye Syndromes","enrollment":10},{"nctId":"NCT05771194","phase":"PHASE4","title":"Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients","status":"COMPLETED","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2021-02-01","conditions":"Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid","enrollment":40},{"nctId":"NCT05320172","phase":"PHASE3","title":"Platelet Rich Plasma in Corneal Surface Diseases","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-06","conditions":"Persistent Corneal Epithelial Defects, Dry Eye","enrollment":70},{"nctId":"NCT05372991","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop","status":"COMPLETED","sponsor":"Cloudbreak Therapeutics, LLC","startDate":"2022-07-20","conditions":"Myopia, Progressive","enrollment":84},{"nctId":"NCT05677945","phase":"NA","title":"3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03","conditions":"Necrotic Primary Molars","enrollment":24},{"nctId":"NCT01375582","phase":"EARLY_PHASE1","title":"Objective Evaluation of Ocular Surface Lubricants in Two Environments","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2011-06","conditions":"Dry Eye","enrollment":20},{"nctId":"NCT05255016","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":"Keratitis, Corneal Ulcer","enrollment":488},{"nctId":"NCT05066698","phase":"PHASE2","title":"ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects","status":"TERMINATED","sponsor":"Noveome Biotherapeutics, formerly Stemnion","startDate":"2022-04-27","conditions":"Persistent Corneal Epithelial Defect","enrollment":8},{"nctId":"NCT05564832","phase":"EARLY_PHASE1","title":"Pharmacological Treatment of Presbyopia","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-08-01","conditions":"Near Vision","enrollment":75},{"nctId":"NCT05314621","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-31","conditions":"Allergic Conjunctivitis","enrollment":61},{"nctId":"NCT05515471","phase":"PHASE3","title":"Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-02-04","conditions":"Treatment of Dry Eye Disease With Meibomian Gland Dysfunction","enrollment":312},{"nctId":"NCT03785340","phase":"PHASE3","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)","status":"COMPLETED","sponsor":"Ocugen","startDate":"2018-12-03","conditions":"Dry Eye","enrollment":252},{"nctId":"NCT03591874","phase":"PHASE3","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease","status":"TERMINATED","sponsor":"Ocugen","startDate":"2018-12-23","conditions":"Graft Versus Host Disease, Ocular Surface Disease, oGVHD","enrollment":59},{"nctId":"NCT05350384","phase":"","title":"An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2021-06-18","conditions":"Purtscher Retinopathy, Pancreatic Cancer","enrollment":1},{"nctId":"NCT04883931","phase":"NA","title":"Mother Milk as a Eye Drop & Premature Retinopathy","status":"COMPLETED","sponsor":"Baskent University","startDate":"2021-05-06","conditions":"Retinopathy of Prematurity","enrollment":101},{"nctId":"NCT05268718","phase":"EARLY_PHASE1","title":"Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-08-01","conditions":"Keratitis, Ulcerative, Antibiotic Resistance, Microbial, Photothermal Therapy","enrollment":20},{"nctId":"NCT05145959","phase":"NA","title":"Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis","status":"UNKNOWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-12-01","conditions":"Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease","enrollment":30},{"nctId":"NCT01738243","phase":"PHASE4","title":"Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2013-12","conditions":"Thyroid Eye Disease","enrollment":2},{"nctId":"NCT03782701","phase":"PHASE4","title":"The Effect of Lumify™ Eyedrops on Eyelid Position","status":"COMPLETED","sponsor":"University of Miami","startDate":"2019-06-18","conditions":"Eyelid Droop","enrollment":43},{"nctId":"NCT04883996","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia","status":"UNKNOWN","sponsor":"Canyon City Eyecare","startDate":"2020-12-01","conditions":"Hyperopia, Myopia","enrollment":60},{"nctId":"NCT04877210","phase":"PHASE1","title":"Effects of Topical Insulin on Levels of Tear Inflammatory Mediators","status":"UNKNOWN","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2020-10-22","conditions":"Dry Eye","enrollment":60},{"nctId":"NCT01893359","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism","status":"TERMINATED","sponsor":"Glaukos Corporation","startDate":"2013-08","conditions":"Hyperopia, Hyperopic Astigmatism","enrollment":2},{"nctId":"NCT04063644","phase":"NA","title":"Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2019-05-30","conditions":"Dry Eye Syndromes, Cataract","enrollment":100},{"nctId":"NCT02804191","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis","status":"COMPLETED","sponsor":"Ocuwize LTD","startDate":"2016-07","conditions":"Conjunctivochalasis","enrollment":62},{"nctId":"NCT04087733","phase":"PHASE4","title":"Effectiveness of Liposomial Ozonized-Oil for Cataract Surgery","status":"COMPLETED","sponsor":"University of Molise","startDate":"2019-10-01","conditions":"Ocular Infections","enrollment":200},{"nctId":"NCT02472223","phase":"NA","title":"Reducing Adenoviral Patient Infected Days","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-03-23","conditions":"Conjunctivitis, Adenoviral Conjunctivitis","enrollment":28},{"nctId":"NCT03862053","phase":"PHASE4","title":"Manuka Eye Droops for Treatment of Allergy","status":"WITHDRAWN","sponsor":"Toyos Clinic","startDate":"2020-01-01","conditions":"Allergic Conjunctivitis","enrollment":""},{"nctId":"NCT04125394","phase":"NA","title":"Efficacy and Tolerance of Hypertonic Sodium Chloride (NaCl 5%) Eye Drops Without Preservatives in Corneal Edema","status":"UNKNOWN","sponsor":"Tiedra Farmacéutica SL","startDate":"2021-02-03","conditions":"Corneal Edema","enrollment":30},{"nctId":"NCT04140422","phase":"NA","title":"Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea","status":"COMPLETED","sponsor":"University Eye Hospital, Freiburg","startDate":"2019-10-24","conditions":"Fuchs' Endothelial Dystrophy","enrollment":68},{"nctId":"NCT02344225","phase":"PHASE2","title":"Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)","status":"COMPLETED","sponsor":"State University of New York - Downstate Medical Center","startDate":"2015-01-01","conditions":"Retinopathy of Prematurity","enrollment":14},{"nctId":"NCT03992482","phase":"PHASE1, PHASE2","title":"IVIG-eye Drops Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Sandeep Jain, MD","startDate":"2019-05-01","conditions":"Dry Eye","enrollment":27},{"nctId":"NCT01614847","phase":"PHASE4","title":"Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears","status":"COMPLETED","sponsor":"Thomas O Salmon, OD, PhD","startDate":"2012-06","conditions":"Dry Eye","enrollment":8},{"nctId":"NCT03245853","phase":"PHASE4","title":"Epi-On Corneal Crosslinking for Keratoconus","status":"COMPLETED","sponsor":"Comprehensive EyeCare of Central Ohio","startDate":"2017-07-18","conditions":"Keratoconus, Keratoconus, Unstable","enrollment":20},{"nctId":"NCT02448043","phase":"NA","title":"Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-06-04","conditions":"Nail Growth Cessation, Intraocular Pressure","enrollment":45},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":"Dry Eye Syndrome","enrollment":326},{"nctId":"NCT04122300","phase":"PHASE3","title":"Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct","status":"COMPLETED","sponsor":"University of Bern","startDate":"2011-05-22","conditions":"Congenita Nasolacrimal Duct Obstruction, Preterm Neonates, Ocular Discharge","enrollment":84},{"nctId":"NCT03739255","phase":"NA","title":"Facilitation of Corneal Re-epithelialization After Photorefractive Keratectomy","status":"UNKNOWN","sponsor":"SynsLaser Kirurgi AS","startDate":"2020-03-01","conditions":"Corneal Erosion","enrollment":20},{"nctId":"NCT03161080","phase":"NA","title":"Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-02-09","conditions":"Dry Eye Syndromes","enrollment":60},{"nctId":"NCT01933464","phase":"PHASE1, PHASE2","title":"An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2013-08","conditions":"Papulopustular Rosacea","enrollment":10},{"nctId":"NCT00981435","phase":"PHASE4","title":"Steroids After Laser Trabeculoplasty for Glaucoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Glaucoma","enrollment":97},{"nctId":"NCT03836664","phase":"PHASE2","title":"A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2017-02-27","conditions":"Migraine","enrollment":25},{"nctId":"NCT00633854","phase":"","title":"High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2008-02","conditions":"Posterior Vitreous Detachment","enrollment":30},{"nctId":"NCT03851172","phase":"PHASE2","title":"Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03-01","conditions":"Cataract, Miosis","enrollment":75},{"nctId":"NCT02417116","phase":"NA","title":"Tear Osmolarity Clinical Utility in Dry Eye Disease","status":"COMPLETED","sponsor":"Aston University","startDate":"2015-06","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT03025945","phase":"NA","title":"Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo","status":"COMPLETED","sponsor":"Intuor Technologies, Inc.","startDate":"2013-10","conditions":"Cystoid Macular Edema","enrollment":662},{"nctId":"NCT01541891","phase":"PHASE2","title":"Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2011-10","conditions":"Dry Eye Syndrome","enrollment":30},{"nctId":"NCT02470429","phase":"NA","title":"Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2015-07-17","conditions":"Dry Eye","enrollment":114},{"nctId":"NCT01733745","phase":"NA","title":"SYSTANE® Family - Meibomian Deficiency","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-02","conditions":"Dry Eye Syndrome","enrollment":26},{"nctId":"NCT01688726","phase":"NA","title":"Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2012-12","conditions":"Dry Eye Syndrome, Lipid Deficiency","enrollment":91},{"nctId":"NCT02483897","phase":"PHASE3","title":"Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion","status":"WITHDRAWN","sponsor":"Queen's University","startDate":"2015-06","conditions":"Corneal Abrasion","enrollment":""},{"nctId":"NCT03417453","phase":"NA","title":"Eye Drop Dispensers: Safety, Efficacy and Comfort.","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"2019-04-01","conditions":"Glaucoma, Cataract, Healthy Subjects","enrollment":50},{"nctId":"NCT02810119","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis","status":"COMPLETED","sponsor":"Ocuwize LTD","startDate":"2016-11","conditions":"Conjunctivochalasis","enrollment":13}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"phase_3","status":"active","brandName":"ophthalmic saline eye drops","genericName":"ophthalmic saline eye drops","companyName":"Jadran Galenski laboratorij d.d.","companyId":"jadran-galenski-laboratorij-d-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ophthalmic saline eye drops work by providing a sterile, isotonic solution to flush out debris and maintain eye health. Used for Dry eye syndrome, Conjunctivitis, Iritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}